ImmunoCellular Therapeutics Ltd (NYSE MKT LLC:IMUC)

0.48
Delayed Data
As of 3:52pm ET
 -0.0133 / -2.70%
Today’s Change
0.43
Today|||52-Week Range
1.04
-34.25%
Year-to-Date
No recent news for ImmunoCellular Therapeutics Ltd.

Today’s Trading

Previous close0.49
Today’s open0.50
Day’s range0.47 - 0.52
Volume315,928
Average volume (3 months)420,046
Market cap$44.5M
Dividend yield--
Data as of 3:52pm ET, 07/27/2015

Growth & Valuation

Earnings growth (last year)0.00%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.35

Competitors

 Today’s
change
Today’s
% change
ABACAoxin Tianli Group I...-0.03-2.44%
OPGNOpGen Inc-0.07-1.91%
--Protea Biosciences G...0.000.00%
PBMDPrima BioMed Ltd+0.03+2.40%
Data as of 3:59pm ET, 07/27/2015

Financials

Next reporting dateAugust 6, 2015
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$0.00
Annual profit (last year)-$9.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Secretary &
Chief Scientific Officer
John S. Yu
President, Chief Executive Officer &
Director
Andrew Gengos
Corporate headquarters
Calabasas, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers